CD44 and colonic neoplasm: These results demonstrated that PSVII@MCP-CaP inhibited the migration and invasion of colon cancer cells by decreasing the protein expression of CD44, MMP-9 and N-cadherin, while increasing the protein expression of E-cadherin.